{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:03:07Z","timestamp":1792670587777,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ijantimicag.2011.11.017","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T06:17:57Z","timestamp":1329200277000},"page":"464-471","source":"Crossref","is-referenced-by-count":71,"title":["Invasive fungal infections in patients with cancer in the Intensive Care Unit"],"prefix":"10.1016","volume":"39","author":[{"given":"Nikolaos V.","family":"Sipsas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/CCM.0b013e31816fc4cd","article-title":"Risk factors for albicans and non-albicans candidemia in the intensive care unit","volume":"36","author":"Chow","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0010","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0015","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005\u20132006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the Prospective Antifungal Therapy Alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the Extended Prevalence of Infection in Intensive Care Unit Study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0045","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0050","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0055","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/cc9033","article-title":"Comparison of albicans vs. non-albicans candidemia in French intensive care units","volume":"14","author":"Leroy","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0060","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/529435","article-title":"Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit","volume":"46","author":"Chow","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0065","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1097\/CCM.0b013e3181760f42","article-title":"Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.","volume":"36","author":"Playford","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0070","doi-asserted-by":"crossref","first-page":"554.e1","DOI":"10.1016\/j.ijantimicag.2008.10.035","article-title":"Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units","volume":"33","author":"Holley","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0075","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","article-title":"Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit","volume":"54","author":"Ostrosky-Zeichner","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0095","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10096-008-0666-4","article-title":"Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit","volume":"28","author":"Faiz","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0100","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00134-009-1619-9","article-title":"Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients","volume":"35","author":"Playford","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Le\u00f3n","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/JCM.01241-08","article-title":"Identification of Candida albicans and Candida glabrata within 1.5hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol","volume":"47","author":"Gherna","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-51-5-433","article-title":"Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species","volume":"51","author":"Sendid","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0125","first-page":"455","article-title":"Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis","volume":"45","author":"Persat","year":"2002","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) \u03b2-d-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0135","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-d-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.01240-10","article-title":"Prospective survey of (1\u21923)-\u03b2-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting","volume":"49","author":"Mohr","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0145","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/JCM.37.6.1871-1875.1999","article-title":"PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies","volume":"37","author":"Morace","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0150","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/JCM.34.9.2175-2179.1996","article-title":"Diagnosis of disseminated candidiasis by measurement of urine d-arabinitol\/l-arabinitol ratio","volume":"34","author":"Lehtonen","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0155","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1007\/s00134-009-1623-0","article-title":"Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis?","volume":"35","author":"Charles","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/338404","article-title":"Pulmonary candidiasis in patients with cancer: an autopsy study","volume":"34","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00134-005-0065-6","article-title":"Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients","volume":"32","author":"Wood","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0175","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0180","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1128\/JCM.00214-08","article-title":"Time to blood culture positivity as a marker for catheter-related candidemia","volume":"46","author":"Ben-Ami","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0185","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1473-3099(03)00831-4","article-title":"Management of Candida species infections in critically ill patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jhin.2007.03.028","article-title":"Candiduria in intensive care units: association with heavy colonization and candidaemia","volume":"66","author":"Toya","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-143-12-200512200-00004","article-title":"Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis","volume":"143","author":"Golan","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0200","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0891-5520(20)30615-2","article-title":"Dermatologic manifestations of infections in neutropenic patients","volume":"8","author":"Bodey","year":"1994","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cid\/cir355","article-title":"Ocular manifestations of candidemia","volume":"53","author":"Oude Lashof","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.11.017_bib0215","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1093\/clinids\/17.Supplement_2.S457","article-title":"Severe candidal infections in neutropenic patients","volume":"17","author":"Swerdloff","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10096-007-0316-2","article-title":"Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study","volume":"26","author":"Dimopoulos","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0225","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0480","series-title":"50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"Impact of therapy on mortality across Candida spp. in patients with invasive candidiasis from randomized clinical trials: a patient level analysis","author":"Andes","year":"2010"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0235","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/AAC.00116-08","article-title":"Association of fluconazole pharmacodynamics with mortality in patients with candidemia","volume":"52","author":"Baddley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0240","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0245","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0250","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomized double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0255","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0260","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijantimicag.2011.11.017_bib0265","first-page":"CD004920","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients","author":"Playford","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archsurg.135.2.160","article-title":"Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance","volume":"135","author":"Rocco","year":"2000","journal-title":"Arch Surg"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0275","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkp251","article-title":"Incidence of candidaemia and relationship with fluconazole use in an intensive care unit","volume":"64","author":"Bassetti","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3324\/haematol.11665","article-title":"Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology","volume":"94","author":"Cornely","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0285","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0290","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jac\/dkm212","article-title":"Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections","volume":"60","author":"Parkins","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0300","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/603585","article-title":"Echinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the Infectious Diseases Society of America","volume":"49","author":"Kontoyiannis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2009.01.006","article-title":"Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study","volume":"34","author":"Sipsas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2011.11.017_bib0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1439-0507.1999.tb00020.x","article-title":"Special pharmacokinetics of fluconazole in septic, obese and burn patients","volume":"42","author":"Pittrow","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0315","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","article-title":"A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis","volume":"48","author":"Betts","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0320","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1128\/AAC.00911-09","article-title":"Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database","volume":"54","author":"Colombo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0330","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijantimicag.2008.06.020","article-title":"Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm","volume":"32","author":"Raad","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0335","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10096-003-1014-3","article-title":"Voriconazole salvage treatment of invasive candidiasis","volume":"22","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0340","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2011.11.017_bib0345","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/421961","article-title":"Combination therapy for invasive mycoses: evaluation of past clinical trial designs","volume":"39","author":"Sobel","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2011.11.017_bib0350","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/421960","article-title":"Design of efficacy trials of cytokines in combination with antifungal drugs","volume":"39","author":"Kullberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/313580","article-title":"Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group","volume":"30","author":"Sobel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0360","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/429722","article-title":"Is it time to abandon the use of amphotericin B bladder irrigation?","volume":"40","author":"Drew","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0365","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhin.2004.01.006","article-title":"Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence","volume":"56","author":"Vandewoude","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0370","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0375","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4065\/75.6.562","article-title":"Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings","volume":"75","author":"Roosen","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0380","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CDLI.10.5.882-885.2003","article-title":"Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients","volume":"10","author":"Digby","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0385","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"\u03b2-d-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0395","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0400","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/509931","article-title":"Medical imaging and timely diagnosis of invasive pulmonary aspergillosis","volume":"44","author":"Vandewoude","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0405","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcrc.2006.03.006","article-title":"Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome","volume":"21","author":"Khasawneh","year":"2006","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0415","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0420","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case\u2013control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0425","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00134-003-2132-1","article-title":"Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients","volume":"30","author":"Marav\u00ed-Poma","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0430","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/587991","article-title":"Reversed halo sign in invasive pulmonary fungal infections","volume":"46","author":"Wahba","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0435","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0440","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0445","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jinf.2010.01.010","article-title":"Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998\u20132009","volume":"60","author":"Campo","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0450","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V90.3.999","article-title":"Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years\u2019 experience at a cancer center and implications for management","volume":"90","author":"Boutati","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0455","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0460","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/503425","article-title":"Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions","volume":"42","author":"Raad","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0465","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365540410017563","article-title":"Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome","volume":"36","author":"Kontoyiannis","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0470","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.11.017_bib0475","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1086\/509579","article-title":"Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989\u20132006","volume":"43","author":"Lamaris","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T03:50:55Z","timestamp":1640749855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0924857912000064"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.11.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}